Efficacy and Safety of Dysport® (AbobotulinumtoxinA) in Pediatric Lower Limb Spasticity

People with Pediatric Lower Limb Spasticity are being asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if your child:

  • Is a female or male aged 2 to 17 years old
  • Has primary diagnosis of PLL spasticity and either previously untreated with abotulinum neurotoxin (BoNT) or previously treated with BoNT


You may not participate in this study if your child:

  • Has known resistance to any BoNT or experienced serious safety issues with previous use of BoNT
  • Has had previous treatment with aminoglycoside antibiotics within the last 30 days
  • Has a current need for surgery in the lower limb
  • Is pregnant and/or a lactating female

Contact Information

Beendu Pujar, Study Coordinator

111 E. 210th Street

Bronx, New York 10467

Phone: (718) 920-4321

Email: bpujar@montefiore.org